Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma - Top-Institutions - MDSpire

Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma

  • By

  • Malin Hultcrantz

  • Hani Hassoun

  • Neha Korde

  • Kylee MacLachlan

  • Sham Mailankody

  • Dhwani Patel

  • Urvi A. Shah

  • Carlyn Rose Tan

  • David J. Chung

  • Oscar B. Lahoud

  • Heather J. Landau

  • Michael Scordo

  • Gunjan L. Shah

  • Sergio A. Giralt

  • Matthew J. Pianko

  • Miranda Burge

  • Kelly Barnett

  • Meghan Salcedo

  • Julia Caple

  • Linh Tran

  • Jenna Blaslov

  • Tala Shekarkhand

  • Selena Hamid

  • David Nemirovsky

  • Andriy Derkach

  • Oluwatobi Arisa

  • Cody J. Peer

  • William D. Figg

  • Saad Z. Usmani

  • Ola Landgren

  • Alexander M. Lesokhin

  • September 19, 2024

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology-Oncology
    • Clinical Pharmacology
    • Supportive Care

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology-Oncology
    • Multiple Myeloma Research
    • Pharmacology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology-Oncology
    • Clinical Trials
    • Pharmacokinetics

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Hematology-Oncology
    • Supportive Care Research

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Hematology-Oncology
    • Clinical Pharmacology

Original Source(s)

Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma

  • by Malin Hultcrantz, Hani Hassoun, Neha Korde, Kylee MacLachlan, Sham Mailankody, Dhwani Patel, Urvi A. Shah, Carlyn Rose Tan, David J. Chung, Oscar B. Lahoud, Heather J. Landau, Michael Scordo, Gunjan L. Shah, Sergio A. Giralt, Matthew J. Pianko, Miranda Burge, Kelly Barnett, Meghan Salcedo, Julia Caple, Linh Tran, Jenna Blaslov, Tala Shekarkhand, Selena Hamid, David Nemirovsky, Andriy Derkach, Oluwatobi Arisa, Cody J. Peer, William D. Figg, Saad Z. Usmani, Ola Landgren, Alexander M. Lesokhin

  • September 19, 2024

Related Content

Prognostic nutritional index, but not NLR or PLR, is linked to survival in multiple myeloma

CRISPR Enables In Vivo CAR T Cell Production

In vivo gene editing strategy generates CAR T cells directly inside the body – sidestepping costly manufacturing

  • March 30, 2026

  • 2 min
Association of genetic ancestry with outcomes and toxicity of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma